In This Article:
As the U.S. market continues to show resilience with major indices like the Dow Jones and S&P 500 on track for a winning month, investors are keenly observing how these trends impact stock valuations. In this environment, identifying undervalued stocks—those trading below their intrinsic value—can be a strategic move for those looking to capitalize on potential market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
Name | Current Price | Fair Value (Est) | Discount (Est) |
Victory Capital Holdings (NasdaqGS:VCTR) | $72.03 | $142.32 | 49.4% |
NBT Bancorp (NasdaqGS:NBTB) | $50.08 | $99.93 | 49.9% |
UMB Financial (NasdaqGS:UMBF) | $126.05 | $243.22 | 48.2% |
West Bancorporation (NasdaqGS:WTBA) | $23.99 | $46.83 | 48.8% |
Five Star Bancorp (NasdaqGS:FSBC) | $33.16 | $63.88 | 48.1% |
Symbotic (NasdaqGM:SYM) | $23.995 | $47.28 | 49.3% |
Privia Health Group (NasdaqGS:PRVA) | $21.66 | $43.17 | 49.8% |
South Atlantic Bancshares (OTCPK:SABK) | $15.50 | $30.26 | 48.8% |
Intuitive Machines (NasdaqGM:LUNR) | $14.45 | $28.66 | 49.6% |
Snap (NYSE:SNAP) | $11.61 | $22.76 | 49% |
Let's dive into some prime choices out of the screener.
Establishment Labs Holdings
Overview: Establishment Labs Holdings Inc. is a medical technology company that manufactures and markets medical devices for aesthetic and reconstructive plastic surgery, with a market cap of approximately $1.29 billion.
Operations: The company generates revenue primarily from its medical products segment, totaling $153.07 million.
Estimated Discount To Fair Value: 16.4%
Establishment Labs Holdings shows potential as an undervalued stock based on cash flows, trading at US$46.07, 16.4% below its estimated fair value of US$55.12. Despite recent volatility and shareholder dilution, the company's revenue is projected to grow significantly faster than the market at 23.6% annually, with earnings expected to rise sharply by over 49% per year. Recent FDA approval for innovative Motiva Implants could enhance future cash flow prospects despite current unprofitability forecasts over three years.
Bloomin' Brands
Overview: Bloomin' Brands, Inc. owns and operates a variety of dining restaurants ranging from casual to fine dining both in the United States and internationally, with a market cap of approximately $1.21 billion.
Operations: The company's revenue segments consist of $3.95 billion from the United States and $600.16 million from international operations.